Treatment of atrial fibrillation.
Atrial fibrillation is a very common arrhythmia and frequently seen by general practitioners. Its rational management entails careful consideration of the goals of therapy. These differ from patient to patient and may include control of ventricular rate, conversion to and maintenance of sinus rhythm and prophylaxis against thromboembolism. This article will focus on the various therapeutic agents available for achieving these aims and will attempt to provide some guidance through what has become a confusing maze of potential therapeutic strategies.
Department of Clinical Pharmacology, St Vincent's Hospital, Darlinghurst, New South Wales.
T J
TJ
Campbell
D000889:Anti-Arrhythmia Agents / Q000494:pharmacology; D001281:Atrial Fibrillation / Q000150:complications / Q000188:drug therapy / Q000628:therapy*; D004077:Digoxin / Q000627:therapeutic use; D006329:Heart Conduction System / Q000187:drug effects; D006801:Humans; D013923:Thromboembolism / Q000209:etiology
D000889:Anti-Arrhythmia Agents; D004077:Digoxin